SLFN11 and breast carcinoma: Most intriguingly, recent findings suggest SLFN11’s involvement in immune regulation, particularly in promoting T-cell infiltration and activation in breast cancer, underscoring its multifaceted role in both cancer therapy and immune modulation (Isnaldi et al., 2019).